CCR9 and non-small cell lung carcinoma: These chemokines, studied by flow cytometry, have been shown to be expressed in cytotoxic (CXCR4) and helper (CCR9 and CCR10) T cells and interfere with the efficacy of immunotherapy in NSCLC.